Med Aditus Pharmaceuticals, Inc. (MAP) is a public benefit corporation with the ambition to disrupt the pharmaceutical manufacturing industry in sub-Saharan Africa and beyond. MAP is delivering technology-driven, patient-centered solutions to the serious medication access problems plaguing sub-Saharan Africa. This problem is amplified by the sluggish growth of pharmaceutical manufacturing capacity that results in heavy reliance on imports, lack of consistent quality, unreliable supply chain, and prevalence of substandard and falsified medicines.
With a first-in-Africa continuous modular manufacturing technology and integration of blockchain in all its operations (manufacturing, supply chain logistics, and patient engagement), Med Aditus Pharmaceuticals is leading the way to leapfrog Africa into the future when it will cease to rely on imported medicines. MAP is a for-profit spinoff of Med Aditus International, Inc., a 501 (c)(3) non-profit corporation.
© Med Aditus Pharmaceuticals 2024
